Cesca Therapeutics' Chief Executive Officer, Chris Xu, To Be The Keynote Speaker At The Cell Therapy World Asia 2018 Conference On September 20, 2018
Published: Sep 13, 2018
RANCHO CORDOVA, Calif., /PRNewswire/ -- Cesca Therapeutics Inc. (NASDAQ: KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, announced today that Chris Xu, PhD, its chief executive officer, will be the keynote speaker on day two of the Cell Therapy World Asia (CTWA) 2018 conference. The event will be held at the Novotel Ambassador Seoul Gangnam Hotel, in Seoul, South Korea, from September 19 to 20, 2018.
Dr. Xu's address, entitled, "Impact of Automated Single-Use Systems on Cost, Quality and Reproducibility of CAR-T Cell Therapy Manufacturing," will begin at 9:00 a.m. KST on September 20th.
Cell Therapy World Asia is Asia-Pacific's only cell therapy-focused regional event. It brings together Asia's best in cell therapy development and manufacturing, and attracts cell therapy companies in South Korea, Japan, China, India, Singapore, Taiwan, and the rest of Asia, to discuss and debate best practices and innovation in the space. For more information, go to: https://www.imapac.com/business_conference/cell-therapy-world-asia.
About Cesca Therapeutics Inc.
View original content:http://www.prnewswire.com/news-releases/cesca-therapeutics-chief-executive-officer-chris-xu-to-be-the-keynote-speaker-at-the-cell-therapy-world-asia-2018-conference-on-september-20-2018-300711880.html
SOURCE Cesca Therapeutics Inc.
Company Codes: NASDAQ-SMALL:KOOL